Antihypertensive treatment and new-onset diabetes mellitus.

Abstract:

:The various antihypertensive regimens have varying effects on glucose metabolism and the development of diabetes mellitus. Recent large hypertension trials have shown great differences in the development of new-onset diabetes among antihypertensive drug therapies. The incidence of diabetes is unchanged or increased by thiazide diuretics and b-adrenergic blockers, and unchanged or decreased by angiotensin-converting enzyme inhibitors, calcium channel blockers, and angiotensin-receptor blockers. The differences in new-onset diabetes mellitus have not influenced the outcome of cardiovascular mortality and morbidity in all of the large clinical trials, but drug-induced diabetes among hypertensive patients is known to carry the same cardiovascular risk as that seen in patients with previously known diabetes; however, it might take years for the increased risk to become apparent.

journal_name

Curr Hypertens Rep

authors

Aksnes TA,Reims HM,Kjeldsen SE,Mancia G

doi

10.1007/s11906-005-0029-9

keywords:

subject

Has Abstract

pub_date

2005-08-01 00:00:00

pages

298-303

issue

4

eissn

1522-6417

issn

1534-3111

journal_volume

7

pub_type

杂志文章,评审
  • Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-gamma system.

    abstract::The metabolic syndrome leads to cardiovascular disease and type 2 diabetes mellitus, through multiple risks, such as insulin resistance, dyslipidemia, hyperinsulinemia, and hypertension. It also represents a disorder of partial genetic background as mutations of the peroxisome proliferator-activated receptor-gamma (PP...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0019-y

    authors: Tuck ML

    更新日期:2005-08-01 00:00:00

  • First Course DASH, Second Course Mediterranean: Comparing Renal Outcomes for Two "Heart-Healthy" Diets.

    abstract:PURPOSE OF REVIEW:To review studies evaluating renal outcomes based on patient adherence to the Mediterranean diet or to the Dietary Approaches to Stop Hypertension (DASH) diet and to determine which diet is most effective in preventing and managing renal disease. RECENT FINDINGS:Both the DASH and Mediterranean diets ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-020-01054-0

    authors: Yazdi F,Morreale P,Reisin E

    更新日期:2020-07-15 00:00:00

  • Comparison Between Automated Office Blood Pressure Measurements and Manual Office Blood Pressure Measurements-Implications in Individual Patients: a Systematic Review and Meta-analysis.

    abstract:PURPOSE OF REVIEW:Automated office blood pressure (AOBP) measurements may provide more accurate estimation of blood pressure (BP) than manual office blood pressure (MOBP) measurements. This systematic review investigated the diagnostic performance of AOBP and MOBP using ambulatory blood pressure measurement (ABPM) as r...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-020-01118-1

    authors: Bo Y,Kwok KO,Chu KK,Leung EY,Yu CP,Wong SY,Lee EK

    更新日期:2021-01-15 00:00:00

  • The genetic basis of primary aldosteronism.

    abstract::Primary aldosteronism is commonly regarded as largely sporadic, but both germline and somatic mutations are increasingly recognized as underlying the condition. Three germline mutations causing familial hyperaldosteronism have been described, dubbed FH I (due to a CYP11B1/CYP11B2 chimera), FH II (localized to chromoso...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-012-0255-x

    authors: Funder JW

    更新日期:2012-04-01 00:00:00

  • Cognitive function in hypertensive children.

    abstract::Young hypertensive adults demonstrate decreased performance on neurocognitive testing compared with that of normotensive controls. There is emerging, preliminary evidence that children with hypertension also manifest cognitive differences when compared to normotensive controls. These preliminary studies consist mostly...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0508-y

    authors: Lande MB,Kupferman JC

    更新日期:2015-01-01 00:00:00

  • Prevalence and diagnosis of primary aldosteronism.

    abstract::Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11.2% in consecutive referred hypertensive patients. When adrenal vein sampling (AVS) is available, two thirds of the cases can be attributed to a tumor and one third of c...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0134-2

    authors: Rossi GP

    更新日期:2010-10-01 00:00:00

  • Ongoing trials: what should we expect after ALLHAT?

    abstract::The publication of the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) results, when used in conjunction with a new meta-analysis, provides hypertension research with a watershed. Data demonstrate clearly that lowering blood pressure is the most important aspect of hypertension man...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析

    doi:10.1007/s11906-003-0044-7

    authors: Wang JG,Staessen JA,Heagerty AM

    更新日期:2003-08-01 00:00:00

  • Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies.

    abstract::Oxidative stress is known to be implicated in the pathogenesis of essential hypertension. Glutathione-S-transferase (GST) enzymes are key components of cellular defense against oxidative stress. The present study aimed to clarify the association between polymorphisms in GST and risk of essential hypertension using a m...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s11906-014-0432-1

    authors: Eslami S,Sahebkar A

    更新日期:2014-06-01 00:00:00

  • Real-World Strategies to Treat Hypertension Associated with Pediatric Obesity.

    abstract:PURPOSE OF REVIEW:To review the most recent literature on current strategies for the treatment of hypertension associated with pediatric obesity. RECENT FINDINGS:Over the last three decades, childhood and adolescent overweight and obesity prevalence in the USA has continued to rise. Unsurprisingly but rather disturbin...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0922-2

    authors: Binka E,Brady TM

    更新日期:2019-02-12 00:00:00

  • Drug-Induced Hypertension: Focus on Mechanisms and Management.

    abstract:PURPOSE OF REVIEW:This review is intended to briefly describe the primary mechanistic pathways by which several common drugs can increase blood pressure. We also propose potential management strategies based on the underlying mechanisms responsible for the blood pressure elevation. RECENT FINDINGS:As hypertension is a...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0736-z

    authors: Lovell AR,Ernst ME

    更新日期:2017-05-01 00:00:00

  • Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.

    abstract::The nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling system is a well-characterized modulator of cardiovascular function, in general, and blood pressure, in particular. The availability of mice mutant for key enzymes in the NO-cGMP signaling system facilitated the identification of interactions with o...

    journal_title:Current hypertension reports

    pub_type: 杂志文章

    doi:10.1007/s11906-012-0320-5

    authors: Thoonen R,Sips PY,Bloch KD,Buys ES

    更新日期:2013-02-01 00:00:00

  • Vasopeptidase inhibition and endothelial function in hypertension.

    abstract::Vasopeptidase inhibitors are a new class of drugs capable of inhibiting both angiotensin-converting enzyme and neutral endopeptidase 24.11. This involves simultaneous inhibition with a single molecule of two key enzymes, ACE and NEP, which are both involved in the regulation of cardiovascular homeostasis in many ways....

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0101-z

    authors: d'Uscio LV,Lüscher TF

    更新日期:2001-12-01 00:00:00

  • Compliance and persistence with newer antihypertensive agents.

    abstract::Individuals with hypertension need to stay on therapy with antihypertensive medication to obtain the full benefits of blood pressure reduction. There are important differences in tolerability across antihypertensive drug classes, and these differences influence the extent to which patients are willing to continue taki...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0021-6

    authors: Gerth WC

    更新日期:2002-12-01 00:00:00

  • Insulin resistance in HIV-related lipodystrophy.

    abstract::Lipodystrophy (LD) associated with HIV infection is a syndrome of abnormal fat distribution observed in HIV-infected patients treated with various antiretroviral agents. In addition, insulin resistance and dyslipidemia can occur in HIV-infected patients with or without LD. The demonstration of the latter metabolic dis...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0067-0

    authors: Mikhail N

    更新日期:2003-04-01 00:00:00

  • New-onset diabetes in treated hypertensive patients.

    abstract::Interpretation of some recent trials in hypertension opened a debate on the clinical value of new-onset diabetes in treated hypertensive patients. It is not completely clear whether certain antihypertensive drug classes are associated with a higher risk for developing type 2 diabetes when compared with other classes. ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0006-3

    authors: Verdecchia P,Angeli F,Reboldi GP,Gattobigio R

    更新日期:2005-06-01 00:00:00

  • Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

    abstract:PURPOSE OF REVIEW:Here, we review the known relations between hypertension and obesity to inflammation and postulate the endogenous protective effect of melatonin and its potential as a therapeutic agent. We will describe the multiple effects of melatonin on blood pressure, adiposity, body weight, and focus on mitochon...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0842-6

    authors: Prado NJ,Ferder L,Manucha W,Diez ER

    更新日期:2018-05-09 00:00:00

  • Non-communicable disease: a welcome and long needed addition to the WHO's 2012 World Heath Statistics.

    abstract::The World Health Organization's annual report World Health Statistics 2012 was recently published. In addition to annually published indicators of health, this year's report contains a highlighted new section on non-communicable diseases and their impact on world health. The section gives particular attention to hyper...

    journal_title:Current hypertension reports

    pub_type: 杂志文章

    doi:10.1007/s11906-012-0303-6

    authors: Owen J,Reisin E

    更新日期:2012-12-01 00:00:00

  • The use of calcium antagonists in the treatment of hypertensive persons with kidney disease.

    abstract::The treatment of hypertension is proven to reduce cardiovascular and renal risk. Combination drug therapy is becoming recognized as a necessity in most patients with hypertension and kidney disease. Allegations about the safe use of calcium antagonists in patients with kidney disease have led to questions and confusio...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0006-5

    authors: Tobe S,Epstein M

    更新日期:2002-06-01 00:00:00

  • How does preeclampsia predispose to future cardiovascular disease?

    abstract::Over the last few decades, there has been increasing emphasis on cardiovascular disease in women and study of female-specific cardiovascular risk factors. Hypertension in pregnancy, and specifically preeclampsia, has been identified as one such risk factor. In this review, we explore the epidemiological evidence for p...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0472-6

    authors: Scantlebury DC,Hayes SN

    更新日期:2014-09-01 00:00:00

  • Chlorthalidone: mechanisms of action and effect on cardiovascular events.

    abstract::How chlorthalidone (CTDN) reduces risk for cardiovascular events (CVEs) can be considered in light of its ability to lower blood pressure (BP) and its non-BP related, pleiotropic effects. The mechanism by which CTDN lowers BP is unclear but may include alterations in whole body regulation and vasodilatory actions on v...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0372-1

    authors: Roush GC,Buddharaju V,Ernst ME,Holford TR

    更新日期:2013-10-01 00:00:00

  • Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

    abstract::The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis [ACE2-Ang-(1-7)-Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective ro...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0512-2

    authors: Bennion DM,Haltigan E,Regenhardt RW,Steckelings UM,Sumners C

    更新日期:2015-02-01 00:00:00

  • Angiotensin, inflammation, hypertension, and cardiovascular disease.

    abstract::We are used to thinking of angiotensin (Ang) II as a regulatory hormone that stimulates constriction of vascular smooth muscle cells, aldosterone release from the adrenal gland, and sodium reabsorption in the renal tubule. We have also become accustomed to understanding that Ang II may be formed and may act locally as...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0082-y

    authors: Luft FC

    更新日期:2001-02-01 00:00:00

  • LCZ696: the next step in improving RAS inhibition?

    abstract::LCZ696 is a single molecule which combines the angiotensin receptor blocker valsartan with the neprilysn inhibitor sacubitril (AHU377). In the recently published PARADIGM-HF trial, LCZ696 proved superior to enalapril in reducing overall mortality, heart failure hospitalizations, and other endpoints in patients with sy...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-015-0548-y

    authors: Gradman AH

    更新日期:2015-05-01 00:00:00

  • Opportunities to Leverage Telehealth Approaches Along the Hypertension Control Cascade in Sub-Saharan Africa.

    abstract:PURPOSE OF REVIEW:To review the current literature on use of telehealth at different stages of the hypertension control cascade in sub-Saharan Africa (SSA) and to discuss opportunities to harness technology infrastructure in SSA to improve population-level blood pressure control. RECENT FINDINGS:Despite the high burde...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0983-2

    authors: Muiruri C,Manavalan P,Jazowski SA,Knettel BA,Vilme H,Zullig LL

    更新日期:2019-08-26 00:00:00

  • The salt paradox and its possible implications in managing hypertensive diabetic patients.

    abstract::Diabetes mellitus is one of the leading causes of end-stage renal disease. The pathogenesis of diabetic nephropathy is still poorly understood, but glomerular injury has been ascribed, at least in part, to glomerular hyperfiltration, which occurs early in the course of diabetes mellitus. Therefore, a better understand...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0089-x

    authors: Vallon V,Blantz R,Thomson S

    更新日期:2005-04-01 00:00:00

  • Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility.

    abstract::Na+,K+-ATPase distributes ions between the intracellular and extracellular space and is responsible for total-body sodium homeostasis. The activity of this ion pump is regulated by catecholamines and peptide hormones; by the ligand of Na+,K+-ATPase, ouabain; and by direct interaction with cytoskeleton proteins. This r...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0032-8

    authors: Aperia A

    更新日期:2001-04-01 00:00:00

  • Spironolactone in congestive heart failure.

    abstract::When a large multicenter research trial is abruptly terminated, it is usually a consequence of significant adverse events. In contrast, when the Randomized Aldactone Evaluation Study (RALES) mortality trial was discontinued 18 months early, it was because of the prominent salutary effect of spironolactone, added to st...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-000-0027-x

    authors: Soberman JE,Weber KT

    更新日期:2000-10-01 00:00:00

  • Mechanism of action of angiotensin-receptor blocking agents.

    abstract::Angiotensin II is the most active hormone of the renin-angiotensin system. In humans, two angiotensin receptors have been identified: AT(1) and AT(2). In adults, most of the effects of angiotensin II are mediated by the AT(1) receptor; the function of the AT(2) receptor is not yet well established. Angiotensin II has ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0036-3

    authors: Siragy HM,Bedigian M

    更新日期:1999-08-01 00:00:00

  • Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.

    abstract:PURPOSE OF REVIEW:Renal sympathetic denervation (RDN) as treatment option for hypertension has a strong rationale; however, variable effects on blood pressure (BP) have been reported ranging from non-response to marked reductions in BP. The absence of a procedural end point for RDN is one of the potential factors assoc...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0821-y

    authors: Hoogerwaard AF,de Jong MR,Elvan A

    更新日期:2018-03-19 00:00:00

  • Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling.

    abstract:PURPOSE OF REVIEW:The aim of the study is to perform a critical assessment of in vitro models of pre-eclampsia using complementary human and cell line-based studies. Molecular mechanisms involved in spiral uterine artery (SUA) remodelling and trophoblast functionality will also be discussed. RECENT FINDINGS:A number o...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0786-2

    authors: McNally R,Alqudah A,Obradovic D,McClements L

    更新日期:2017-10-23 00:00:00